Display options
Share it on

Tob Induc Dis. 2006 Aug 15;3(2):17-33. doi: 10.1186/1617-9625-3-2-17.

Impact of Nicotine Replacement Therapy on post-cessation mood profile by pre-cessation depressive symptoms.

Tobacco induced diseases

Tellervo Korhonen, Taru H Kinnunen, Arthur J Garvey

Affiliations

  1. Tobacco Dependence Treatment and Research, Harvard School of Dental Medicine, Boston, MA, USA.

PMID: 19570294 PMCID: PMC2633369 DOI: 10.1186/1617-9625-3-2-17

Abstract

We evaluated the effects of Nicotine Replacement Therapy (NRT) on the Profile of Mood States (POMS), testing whether pre-cessation depressive symptoms modify NRT's effects on POMS. Out of 608 smokers attempting to quit with NRT, this secondary analysis included 242 participants abstinent for at least two weeks. We measured pre-cessation depressive symptoms with the Center for Epidemiological Studies Depression Scale. At 1, 7, and 14 post-cessation days we examined 6 self-reported POMS, i.e. feeling 'anxious', 'sad', 'confused', 'angry', 'energetic' and 'fatigue'. The results of the ANCOVA models suggested no NRT effects on feeling anxious, energetic or fatigue. We found that pre-cessation depression modified NRT effects in some specific mood states, such as depression by NRT- interaction effects on feeling confused and feeling angry. On average, the depressed participants in the placebo groups had the highest symptom scores. However, those depressed in NRT conditions did not have significantly higher symptom scores compared to the non-depressed groups. In treating those negative moods NRT may be particularly important for persons with depressive symptoms before cessation.

References

  1. Am J Psychiatry. 1993 Apr;150(4):546-53 - PubMed
  2. J Consult Clin Psychol. 1996 Aug;64(4):791-8 - PubMed
  3. J Abnorm Psychol. 2002 Nov;111(4):670-5 - PubMed
  4. Addiction. 1993 Dec;88(12):1699-705 - PubMed
  5. Health Psychol. 1998 Jan;17(1):56-62 - PubMed
  6. Nicotine Tob Res. 2005 Feb;7(1):47-57 - PubMed
  7. JAMA. 1991 Dec 11;266(22):3133-8 - PubMed
  8. Psychopharmacology (Berl). 1993;111(3):271-7 - PubMed
  9. Addict Behav. 1997 Nov-Dec;22(6):783-7 - PubMed
  10. Addict Behav. 2000 Jul-Aug;25(4):549-57 - PubMed
  11. BMJ. 2004 Jun 26;328(7455):1519 - PubMed
  12. J Consult Clin Psychol. 2003 Aug;71(4):657-63 - PubMed
  13. Addict Behav. 2001 May-Jun;26(3):311-27 - PubMed
  14. Nicotine Tob Res. 2005 Feb;7(1):91-102 - PubMed
  15. BMJ. 1998 Apr 18;316(7139):1236-8 - PubMed
  16. Nicotine Tob Res. 2000 Feb;2(1):53-63 - PubMed
  17. Int J Clin Pharmacol Ther. 2002 Sep;40(9):404-18 - PubMed
  18. Nicotine Tob Res. 2001 Nov;3(4):311-23 - PubMed
  19. Nicotine Tob Res. 2005 Dec;7(6):859-70 - PubMed
  20. JAMA. 1989 Sep 1;262(9):1191-5 - PubMed
  21. Nicotine Tob Res. 2004 Aug;6(4):743-5; author reply 747-9; discussion 751-2 - PubMed
  22. Nicotine Tob Res. 2003 Apr;5(2):169-80 - PubMed
  23. Neuropsychopharmacology. 2001 Apr;24(4):350-8 - PubMed
  24. JAMA. 1990 Sep 26;264(12):1541-5 - PubMed
  25. J Addict Dis. 1998;17(1):35-46 - PubMed
  26. Health Psychol. 1986;5 Suppl:3-11 - PubMed
  27. J Consult Clin Psychol. 1999 Aug;67(4):547-54 - PubMed
  28. Int J Psychiatry Med. 1990;20(3):259-77 - PubMed

Publication Types